BEIDA JADE BIRD (08095) announced its interim results, with a profit attributable to shareholders of 74.48 million yuan, turning from a loss to a profit compared to the same period last year.
Beijing University Blue Sky (08095) announced its interim results for the six months ending June 30, 2026, reporting revenue of 230 million yuan, a decrease of 23.54% year-on-year; the profit attributable to shareholders was 74.48 million yuan, compared to a loss of 20.077 million yuan in the same period last year; earnings per share were 4.92 cents.
BEIDA JADE BIRD (08095) released its interim results for the six months ended June 30, 2026, reporting revenue of 230 million yuan, a decrease of 23.54% year-on-year; the profit attributable to shareholders was 74.48 million yuan, compared to a loss of 20.077 million yuan in the same period last year; earnings per share were 4.92 cents.
Related Articles

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

RECOMMEND





